← FDA DRUG APPROVALS

FDA NDA · NDA008855

MILONTIN

Sponsor: PARKE DAVIS

APPLICATION
NDA008855
TYPE
NDA
ORIGINAL APPROVAL
1953-09-08
LATEST ACTION
1977-03-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

MILONTINDiscontinued
PHENSUXIMIDE 500MG · CAPSULE · ORAL

Approval history

1977-03-09Labeling · Supplement 3AP
1953-09-08Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →